US20220142662A1 - Streamlined Treatment of Clot Removal, Angioplasty and Prevention of Restenosis Using a Single Integrated Intravascular Device - Google Patents
Streamlined Treatment of Clot Removal, Angioplasty and Prevention of Restenosis Using a Single Integrated Intravascular Device Download PDFInfo
- Publication number
- US20220142662A1 US20220142662A1 US17/585,473 US202217585473A US2022142662A1 US 20220142662 A1 US20220142662 A1 US 20220142662A1 US 202217585473 A US202217585473 A US 202217585473A US 2022142662 A1 US2022142662 A1 US 2022142662A1
- Authority
- US
- United States
- Prior art keywords
- self
- stentriever
- expanding
- pusher member
- semi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000037803 restenosis Diseases 0.000 title description 12
- 238000011282 treatment Methods 0.000 title description 11
- 238000002399 angioplasty Methods 0.000 title description 9
- 230000002265 prevention Effects 0.000 title description 6
- 239000012530 fluid Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 208000031481 Pathologic Constriction Diseases 0.000 abstract description 27
- 208000037804 stenosis Diseases 0.000 abstract description 27
- 230000036262 stenosis Effects 0.000 abstract description 27
- 238000003384 imaging method Methods 0.000 abstract description 8
- 230000000916 dilatatory effect Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 description 14
- 208000007536 Thrombosis Diseases 0.000 description 8
- 210000001367 artery Anatomy 0.000 description 8
- 238000013151 thrombectomy Methods 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 5
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- -1 Polyethylene Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22031—Gripping instruments, e.g. forceps, for removing or smashing calculi
- A61B17/22032—Gripping instruments, e.g. forceps, for removing or smashing calculi having inflatable gripping elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
- A61B2017/00561—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated creating a vacuum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22001—Angioplasty, e.g. PCTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22001—Angioplasty, e.g. PCTA
- A61B2017/22002—Angioplasty, e.g. PCTA preventing restenosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22061—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation for spreading elements apart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22094—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for for crossing total occlusions, i.e. piercing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A61B2017/2212—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having a closed distal end, e.g. a loop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A61B2017/2217—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions single wire changing shape to a gripping configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9528—Instruments specially adapted for placement or removal of stents or stent-grafts for retrieval of stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/109—Balloon catheters with special features or adapted for special applications having balloons for removing solid matters, e.g. by grasping or scraping plaque, thrombus or other matters that obstruct the flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1097—Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon
Definitions
- the present invention relates to an intravascular device.
- the present invention is directed to an improved single integrated intravascular device including a stentriever and balloon providing multifunctional treatment including clot removal, angioplasty and/or prevention of restenosis using a single device.
- Mechanical thrombectomy devices e.g., stent trievers or stentrievers
- stent trievers or stentrievers are commonly used to remove a clot, thrombus, occlusion or blockage that is occluding blood flow in an artery.
- a guidewire alone may be advanced through an artery across and beyond a target clot, thrombus, occlusion or blockage followed thereafter by a microcatheter tracked over the guidewire.
- the microcatheter together with the guidewire disposed in the lumen of the microcatheter may be advanced simultaneously as a single unit through the artery across and beyond the target clot.
- the guidewire is proximally withdrawn and the mechanical thrombectomy device (e.g., stent retriever or stentriever) is advanced through the lumen of the microcatheter so that the stentriever crosses (traverses) the target clot.
- the microcatheter is proximally withdrawn unsheathing (i.e., freeing) the mechanical thrombectomy device coinciding with the occluding blockage. No longer radially constrained by the microcatheter, the mechanical thrombectomy device automatically radially self-expands to an enlarged maximum diameter.
- the stentriever As the stentriever self-expands engaging the thrombus therein, it applies a radial force that compresses the thrombus against the vessel wall immediately restoring partial reperfusion of the distal vasculature. After passage of a predetermined period of time (e.g., approximately 2-5 minutes) the thrombus is sufficiently embedded in the spaces or openings between struts of the expanded stentriever.
- the microcatheter and mechanical thrombectomy device with the clot captured, embedded or engaged therein are simultaneously withdrawn as a single unit from the body.
- an underlying stenosis i.e., narrowing of the artery due to build-up of plaque
- a separate angioplasty procedure is performed using a separate device, e.g., a balloon catheter.
- a balloon catheter Once the catheter has been advanced to coincide with the narrowed opening of the vessel a balloon disposed on the end of the catheter is inflated. As the balloon expands, the plaque is pushed radially outward against the inner walls of the vessel thereby restoring blood flow therethrough.
- a mesh stent separate from the stentriever and balloon catheter may be deployed and left permanently implanted in the body to maintain patency.
- An aspect of the present invention is directed to a streamlined multifunctional treatment to carry out clot capture, angioplasty and/or prevention of restenosis using a single integrated intravascular device comprising a self-expanding stentriever and semi-compliant balloon eliminating the need to perform separate medical procedures using separate devices.
- Another aspect of the present invention relates to a single integrated intravascular device including a pusher member having a proximal end, an opposite distal end; and a self-expanding stentriever comprising an open scaffolding formed by multiple struts secured together.
- the self-expanding stentriever is transitionable upon withdraw of an externally applied mechanical force imposed by the microcatheter between a compressed state having a reduced diameter and a self-expanded state having an enlarged diameter.
- Proximal and distal ends of the self-expanding stentriever are secured to the pusher member at respective proximal and distal securement points, the self-expanding stentriever is detachable or releasable from the pusher member at the respective proximal and distal securement points.
- the device further including a semi-compliant balloon housed within the self-expanding stentriever and secured to the pusher member extending axially through the semi-compliant balloon; and an inflation lumen defined axially in the pusher member in fluid communication with the semi-compliant balloon.
- While another aspect of the present invention is directed to a method for using a single integrated intravascular device as described in the preceding paragraph.
- the method including the step of advancing a guidewire and microcatheter into a vessel across a target clot.
- the guidewire is then proximally withdrawn while maintaining in position the microcatheter in the vessel traversing the target clot.
- the self-expanding stentriever is in the compressed state with the semi-compliant balloon in a deflated state housed therein, the single integrated intravascular device is loaded into the lumen of the microcatheter.
- the single integrated intravascular device is advanced through the lumen of the microcatheter using the pusher member so that the self-expanding stentriever coincides with the target clot.
- the microcatheter is proximally withdrawn from the vessel, while the single integrated intravascular device is maintained within the vessel crossing the target clot.
- the self-expanding stentriever when unsheathed from the microcatheter automatically transitions to the self-expanded state engaging the target clot in the open scaffolding of the self-expanding stentriever, while the semi-compliant balloon housed within the self-expanding stentriever is maintained in a deflated state so as not to interfere with engagement and subsequent embedding of the target clot in the self-expanding stentriever.
- Still another aspect of the present invention relates to a method for using a single integrated intravascular device including a stentriever and semi-compliant balloon housed within the stentriever.
- the single integrated intravascular device is first introduced into a vessel to traverse a target clot. Thereafter, the stentriever is deployed to a self-expanded state and the target clot is embedded therein.
- the single integrated intravascular device with the embedded clot therein is removed from the vessel. Through imaging, an underlying residual stenosis in the vessel is detected at an original position of the captured target clot. Whereupon, the single integrated intravascular device is reintroduced into the vessel to a location where the stentriever coincides with the detected underlying residual stenosis.
- the stentriever is deployed so that it transitions from a compressed state to a self-expanded state.
- the semi-compliant balloon is inflated with inflation media to enlarge the stentriever to a hyper-expanded state having a diameter larger than the self-expanded state thereby dilating the vessel at the location of the detected underlying residual stenosis while simultaneously completely detaching or releasing the stentriever from a remaining portion of the single integrated intravascular device.
- the semi-compliant balloon is now collapsed by purging the inflation media therefrom.
- the remaining portion of the single integral intravascular device is proximally withdrawn from the vessel, while maintaining in position within the vessel at the position of the detected underlying residual stenosis the detachable or releasable portion of the stentriever in the self-expanded state.
- FIG. 1 is a cross-sectional view of an exemplary single integrated intravascular device including a self-expanding stentriever and semi-compliant balloon in accordance with the present invention
- FIG. 2A depicts the guidewire and microcatheter positioned across the target clot in a vessel
- FIG. 2B depicts, following proximal withdraw of the guidewire from the vessel, advancement through the lumen of the microcatheter the present inventive single integrated intravascular device of FIG. 1 so that the self-expanding stentriever traverses the target clot in the vessel;
- FIG. 2C depicts, following proximal withdraw of the microcatheter from the vessel, unsheathing and automatic deployment of the self-expanding stentriever to a radially self-expanded state engaging the target clot in the open spaces of the scaffolding;
- FIG. 2D depicts the self-expanding stentriever while in a radially self-expanded state with the clot embedded therein being withdrawn proximally into a larger diameter proximal catheter;
- FIG. 2E depicts the presence of an underlying residual stenosis at the original site in the vessel of the target clot, the guidewire and microcatheter being reintroduced, simultaneously or in succession, into the vessel to a position coinciding with the underlying residual stenosis;
- FIG. 2F depicts, following proximal withdraw of the guidewire from the vessel, reloading of the present inventive single integrated intravascular device of FIG. 1 into the lumen of the microcatheter so that the self-expanding stentriever coincides with the underlying residual stenosis;
- FIG. 2G depicts, following proximal withdraw of the microcatheter from the vessel, unsheathing and automatic deployment of the self-expanding stentriever to a radially self-expanded state at the location of the detected underlying residual stenosis;
- FIG. 2H depicts, inflation of the semi-compliant balloon housed within the self-expanding stentriever, to dilate the vessel at the detected underlying residual stenosis; the self-expanding stentriever is illustrated in a hyper-expanded state larger in diameter than that when in the self-expanded state of FIG. 2G ;
- FIG. 2I depicts, following fracture of the frangible sections of the scaffolding of the self-expanding stentriever when deformed by the inflated semi-compliant balloon and thereafter deflating of the semi-compliant balloon, proximal withdraw from the vessel as a single unit the remnant portions of the self-expanding stentriever that remain secured to the pusher shaft along with the deflated balloon, while permanently maintaining in position within the vessel the detachable portion of the self-expanding stentriever in the self-expanded state to prevent restenosis;
- FIG. 2J is an enlarged area of a section II(J) of struts of the self-expanding stentriever in FIG. 2H having a thinner cross-section to promote fracturing when the semi-compliant balloon is inflated causing the self-expanding stentriever to transition to a hyper-expanded state;
- FIG. 3A is a cross-sectional view of an alternative configuration of the present inventive single integrated intravascular device including a self-expanding stentriever and semi-compliant balloon in accordance with the present invention; wherein distal and proximal ends of the self-expanding stentriever are releasably secured to the pusher member via respective distal and proximal sleeves;
- FIG. 3B is a cross-sectional view of the single integrated intravascular device of FIG. 3A after the self-expanding stentriever has been unsheathed from the microcatheter and transitioning to the self-expanded state;
- FIG. 3C is a cross-sectional view of the single integrated intravascular device of FIG. 3A when the semi-compliant balloon has been inflated resulting in radial expansion of the self-expanding stentriever to a hyper-expanded state (having a greater diameter than the self-expanded state in FIG. 3B ) simultaneously with a foreshortening axially of the respective proximal and distal ends of the self-expanding stentriever; and
- FIG. 3D is a cross-sectional view of the single integrated intravascular device of FIG. 3A with the proximal and distal ends of self-expanding stentriever released or disengaged from the respective proximal and distal sleeves allowing the released self-expanded stentriever to return to its pre-formed shape.
- distal or “proximal” are used in the following description with respect to a position or direction relative to the treating physician or medical interventionalist. “Distal” or “distally” are a position distant from or in a direction away from the physician or interventionalist. “Proximal” or “proximally” or “proximate” are a position near or in a direction toward the physician or medical interventionalist.
- occlusion clot
- thrombus or “blockage” are used interchangeably.
- the present invention is directed to a single integrated intravascular device that includes a self-expanding stentriever and a semi-compliant balloon.
- semi-compliant balloon is herein defined as a balloon that distends approximately 10% of the diameter between the nominal pressure (pressure at labeled diameter) and the rated burst pressure (95% confidence that 99.9% will not fail at or below rated burst).
- Exemplary semi-compliant balloon materials include, but are not limited to, Polyethylene, Polyolefin Copolymer or Polyamide (Nylon).
- multiple intravascular treatments clot removal; angioplasty; prevention of restenosis
- multiple intravascular treatments or procedures may now be carried out in a single streamlined procedure saving time, reducing device exchanges and providing the interventionalist flexibility to permanently deploy a stent scaffold at any point in the thrombectomy procedure.
- This single integrated intravascular device may be used to carry out multiple intravascular treatments or procedures including clot capture/removal, angioplasty and/or prevention of restenosis.
- the present inventive single integrated intravascular device 100 includes a mechanical thrombectomy device (e.g., self-expanding stentriever) 115 comprising an open mesh, cage, scaffolding, or skeleton formed by a plurality of struts connected together with spaces or openings 116 defined therebetween through which the clot may be engaged, captured and over time embed.
- a mechanical thrombectomy device e.g., self-expanding stentriever
- Self-expanding stentriever 115 is made of an automatically self-expanding material (e.g., a biocompatible superelastic shape memory material such as Nitinol (e.g., Nickel-Titanium)) that may be crimped-down or reduced in diameter to a compressed state receivable within a lumen of a microcatheter, as described in further detail below.
- a biocompatible superelastic shape memory material such as Nitinol (e.g., Nickel-Titanium)
- a deflated semi-compliant balloon 120 Housed within the self-expanding stentriever 115 .
- Proximal and distal ends of each of the semi-compliant balloon 120 and self-expanding stentriever 115 are secured (e.g., fused) at respective proximal and distal securement points 117 , 117 ′ to a proximal shaft or pusher member 125 .
- a proximal section of the pusher member 125 extends proximally to and axially completely through the semi-compliant balloon 120
- a distal section of the pusher member 125 extends outward beyond the distal end of the semi-compliant balloon 120 and self-expanding stentriever 115 .
- the stiffness of pusher member 125 preferably varies along its axial length from a stiff proximal end relative to a more pliable distal end extending axially beyond the semi-compliant balloon and self-expanding stentriever.
- an inflation/deflation lumen 127 for receiving an inflation media (e.g., 50% contrast saline solution) used to inflate/deflate the semi-compliant balloon 120 .
- an inflation/deflation lumen 127 is in fluid communication with the semi-compliant balloon, without extending axially beyond the semi-compliant balloon into the distal section of the pusher member 125 .
- multifunctional intravascular medical procedures i.e., clot capture/retrieval; angioplasty; and thereafter implantation of a permanent stent to prevent restenosis
- these separate medical treatments have been streamlined using the present inventive single integrated intravascular device.
- a general overview of the multifunctional application of the present inventive single integrated intravascular device is provided, the specific details of operating the device follow in the description thereafter.
- the target clot may be captured using the self-expanding stentriever component of the present inventive single integrated intravascular device and withdrawn into a proximal catheter. Thereafter, imaging may be conducted to determine whether underlying residual stenosis is present at the original site of the target clot.
- the same single integrated intravascular device 100 may be reloaded into the microcatheter and reintroduced back to the original site of the target clot where the underlying residual stenosis has been detected.
- angioplasty may be performed on the underlying residual stenosis dilating the opening of the artery to restore blood flow therethrough by inflating the semi-compliant balloon housed within the self-expanding stentriever. With inflation of the semi-compliant balloon the self-expanding stentriever may be detached or released (freed) from the remaining portion of the single integrated intravascular device.
- the remaining portion of the single integrated intravascular device may thereafter be withdrawn leaving behind permanently in the vessel the detached or released (freed) portion of the self-expanding stentriever while in the self-expanded state to prevent elastic vessel recoil or restenosis.
- the present inventive single integrated intravascular device employs a semi-compliant balloon
- the single integrated device prior to introduction into the body the single integrated device is prepped by removing, purging, or exhausting residual air from the device. Removal of the residual air may be achieved by applying a vacuum using a syringe 110 or other mechanical device connected to a proximal hub 105 .
- the exemplary illustration in FIG. 1 shows a single inflation/deflation lumen 127 , however, it is contemplated and within the intended scope of the present invention for separate inflation and deflation lumen (arranged coaxially or side-by-side) to be employed, as desired.
- use of the present inventive single integrated device 100 begins by introducing a guidewire 200 into an artery 205 and advancing the guidewire across the target clot, thrombus, occlusion or blockage 210 , as shown in FIG. 2A . Thereafter, a microcatheter 220 having a lumen 225 defined axially therein is tracked over the guidewire 200 until its distal end 230 crosses and emerges distally beyond the target clot 210 . Guidewire 200 is then proximally withdrawn from the vessel while maintaining the position of the microcatheter 220 in the vessel 205 traversing the target clot 210 . Referring to FIG.
- the single integrated intravascular device 100 is introduced into the lumen 225 of the microcatheter 220 .
- the single integrated intravascular device 100 is advanced through the lumen 225 of the microcatheter 220 using the pusher member 125 so that the self-expanding stentriever 115 traverses the target clot 210 .
- the microcatheter 220 is then retracted or withdrawn proximally while the single integrated intravascular device 100 remains in place within the vessel 205 traversing/crossing the target clot 210 .
- the microcatheter 220 is proximally retracted from the vessel 205 it unsheathes or frees the self-expanding stentriever 115 disposed therein which automatically transitions to a self-expand state having an enlarged diameter thereby engaging the target clot 210 in the open spaces 116 of the mesh or scaffolding structure.
- the semi-compliant balloon 120 housed therein remains in a deflated state so as not to interfere with engagement and subsequent embedding of the target clot 210 .
- the target clot 210 sufficiently embeds in the spacings or openings 116 of the scaffolding of the self-expanding stentriever 115 .
- the target clot 210 embedded in the self-expanding stentriever 115 together with the deflated semi-compliant balloon 120 housed therein are withdrawn proximally as a single unit and received in a proximal catheter 235 having a diameter sufficiently large in size to accommodate the self-expanding stentriever 115 (which in a self-expanded state) without compressing and stripping off the target clot, as depicted in FIG. 2D .
- the functionality of the present inventive single integrated intravascular device does not necessarily end. Now that the self-expanding stentriever 115 and captured target clot 210 therein have been received in the proximal catheter 235 and withdrawn from the vessel 205 , the presence of any underlying residual stenosis 215 at the original site of the captured target clot may be detected through imaging.
- the single integrated intravascular device 100 may be cleaned and reloaded into the microcatheter 220 . Similar to that in FIG. 2A (but the target clot 210 has already been captured and removed from the vessel), the guidewire 200 and microcatheter 220 , either successively (one after the other) or simultaneously at the same time, are reintroduced and tracked through the vessel 205 to the detected underlying residual stenosis 215 , as illustrated in FIG. 2E . Guidewire 200 is then proximally withdrawn from the vessel leaving the microcatheter 220 in position coinciding with the underlying residual stenosis 215 .
- the single integrated intravascular device 100 is reloaded into the microcatheter 220 and advanced so that the self-expanding stentriever 115 coincides with the underlying residual stenosis 215 , as shown in FIG. 2F .
- microcatheter 220 is withdrawn proximally from the vessel 205 unsheathing the self-expanding stentriever 115 allowing it to automatically enlarge radially to the self-expanded state.
- Self-expanding stentriever 115 With the self-expanding stentriever 115 in the self-expanded state, the syringe 110 dispenses under pressure the inflation media through the inflation lumen 127 of the pusher member 125 filling the semi-compliant balloon 120 .
- Self-expanding stentriever 115 may be configured so that some portions of the scaffolding or struts include weakened or frangible sections 111 disposed at multiple strut locations proximate the proximal and distal securement points to the pusher member 125 .
- the frangible sections 111 of the self-expanding stentriever may be designed as sections of the struts having a thinner cross-section (as depicted in FIG. 2J ), or as struts with focal stress risers (notches).
- the self-expanding stentriever 115 hyper-expands to a diameter larger than the self-expanding state while adopting the curved contour of the inflated semi-compliant balloon, as shown in FIG. 2H .
- the inflated balloon enlarges or dilates the narrow opening of the vessel in which there is a build-up of plaque improving blood flow therethrough.
- a negative pressure is applied using the syringe 110 expelling the inflation media via the inflation/deflation lumen 127 of the pusher member 125 so that the collapsed semi-compliant balloon 120 may be withdrawn from the vessel.
- the detachable portion 130 ′ of the self-expanding stentriever transitions from the hyper-expanded state ( FIG. 2H ) back to the smaller diameter self-expanded state ( FIG. 2I ).
- 2I further depicts the severed detachable portion 130 ′ of the self-expanding stentriever maintained in the vessel 205 in the self-expanded state, while the remnant portions 130 secured to the pusher member 125 together with the deflated semi-compliant balloon 120 are proximally withdrawn from the vessel as a single unit.
- Detachable portion 130 ′ of the self-expanding stentriever 115 in the self-expanded state remains permanently in the vessel at the position in which residual stenosis was detected to prevent restenosis.
- the probability of restenosis (re-narrowing of the opening of the artery) that occurs (typically within approximately 6-12 months) following dilation of the vessel opening by the inflated balloon is prevented or reduced by the detachable portion of the self-expanding stentriever permanently remaining in place in the vessel.
- FIG. 3A depicts an alternative configuration, wherein the self-expanding stentriever 315 (while in a crimped state) with the deflated semi-compliant balloon 320 disposed therein together are advanced through the microcatheter 370 to a target site in the vessel.
- Proximal and distal end struts of the self-expanding stentriever 315 are secured to the pusher member 325 via proximal and distal sleeves or end caps 385 , 385 ′, respectively, that remain fixed in position axially relative to one another.
- the self-expanding stentriever 315 no longer constrained by the microcatheter automatically self-expands increasing in diameter to a self-expanded state, as shown in FIG. 3B .
- the self-expanding stentriever 315 while in the self-expanded state may be employed similar to that described above with respect to FIGS. 2A-2J to engage and remove the target clot. If, subsequent to removing the target clot, through imaging a stenosis is detected at the site of the removed target clot, the device may be cleaned and reloaded into the vessel to the target site, once again following the description and procedure above regarding the design of FIGS. 2A-2J .
- the microcatheter 370 is proximally withdrawn.
- the unsheathing of the crimped-down self-expanding stentriever 315 increases its diameter to a self-expanded state, nevertheless the distal and proximal end struts of the self-expanding stentriever remain secured to the pusher member 325 beneath the respective proximal and distal sleeves 385 , 385 ′.
- the semi-compliant balloon 320 is inflated causing the self-expanding stentriever 315 to transition to a hyper-expanded state (i.e., having a diameter greater than that in a self-expanded state when the self-expanding stentriever is unsheathed by the microcatheter but remains secured by the proximal and distal sleeves 385 , 385 ′, as shown in FIG. 3B ).
- a hyper-expanded state i.e., having a diameter greater than that in a self-expanded state when the self-expanding stentriever is unsheathed by the microcatheter but remains secured by the proximal and distal sleeves 385 , 385 ′, as shown in FIG. 3B ).
- Inflation of semi-compliant balloon 320 to the hyper-expanded state increases in diameter (direction traverse to the axial direction—as denoted by the larger arrows) and, in turn, causes a foreshortening of the self-expanding stentriever (axial direction—as denoted by the smaller arrows drawn towards one another) to such extent that the distal and proximal end struts of the self-expanding stentriever are freed from or disengage (no longer secured by) the proximal and distal sleeves 385 , 385 ′. Once released or detached from the proximal and distal sleeves (as shown in FIG.
- the distal and proximal end struts of the self-expanding stentriever expand automatically in diameter to their pre-formed shape in direct physical contact with the inner wall of the vessel at the target site of the stenosis.
- semi-compliant balloon 320 may be deflated and removed proximally along with the sleeves 385 , 385 ′ and pusher member 325 , while the detached (freed) self-expanding stentriever 315 permanently remains in physical contact with the inner wall of the vessel 305 at the target site.
- the step of removing the target clot may be bypassed entirely.
- the interventionalist may proceed directly to inflating the semi-compliant balloon causing the self-expanding stentriever to transition to a hyper-expanded state and detaching/releasing itself from the pusher member, without attempting to remove or withdraw the clot.
- the semi-compliant balloon After deflation, the semi-compliant balloon is withdrawn together with the pusher member, leaving in place at the site of the stenosis the detached/released self-expanding stentriever in the self-expanded state in physical contact against the wall of the vessel.
- the present inventive single integrated intravascular device is used to perform multifunctional treatment including: (i) capturing and removing the target clot; (ii) dilating the narrowed opening of a vessel in which an underlying residual stenosis is detected beneath the target clot after removal; and/or (iii) permanently maintaining the detachable/releasable (freed) self-expanding stentriever in the vessel at the location of the detected underlying residual stenosis to prevent restenosis.
Abstract
Description
- This application is a continuation of U.S. Ser. No. 16/508,121, filed on Jul. 10, 2019, which is herein incorporated by reference in its entirety.
- The present invention relates to an intravascular device. In particular, the present invention is directed to an improved single integrated intravascular device including a stentriever and balloon providing multifunctional treatment including clot removal, angioplasty and/or prevention of restenosis using a single device.
- Mechanical thrombectomy devices (e.g., stent trievers or stentrievers) are commonly used to remove a clot, thrombus, occlusion or blockage that is occluding blood flow in an artery. Using standard imaging techniques (e.g., X-ray radiology), a guidewire alone may be advanced through an artery across and beyond a target clot, thrombus, occlusion or blockage followed thereafter by a microcatheter tracked over the guidewire. Alternatively, the microcatheter together with the guidewire disposed in the lumen of the microcatheter may be advanced simultaneously as a single unit through the artery across and beyond the target clot. In either case, with the microcatheter in position at the target site, the guidewire is proximally withdrawn and the mechanical thrombectomy device (e.g., stent retriever or stentriever) is advanced through the lumen of the microcatheter so that the stentriever crosses (traverses) the target clot. Now the microcatheter is proximally withdrawn unsheathing (i.e., freeing) the mechanical thrombectomy device coinciding with the occluding blockage. No longer radially constrained by the microcatheter, the mechanical thrombectomy device automatically radially self-expands to an enlarged maximum diameter. As the stentriever self-expands engaging the thrombus therein, it applies a radial force that compresses the thrombus against the vessel wall immediately restoring partial reperfusion of the distal vasculature. After passage of a predetermined period of time (e.g., approximately 2-5 minutes) the thrombus is sufficiently embedded in the spaces or openings between struts of the expanded stentriever. The microcatheter and mechanical thrombectomy device with the clot captured, embedded or engaged therein are simultaneously withdrawn as a single unit from the body.
- Sometimes, an underlying stenosis (i.e., narrowing of the artery due to build-up of plaque) present behind the clot initially goes undetected, revealed to the interventionalist only after the thrombus itself has been removed. In such circumstance, to restore blood flow in the artery a separate angioplasty procedure is performed using a separate device, e.g., a balloon catheter. Once the catheter has been advanced to coincide with the narrowed opening of the vessel a balloon disposed on the end of the catheter is inflated. As the balloon expands, the plaque is pushed radially outward against the inner walls of the vessel thereby restoring blood flow therethrough. If necessary, in a third and separate procedure from that of the removal of the clot and opening of the narrowed vessel, a mesh stent separate from the stentriever and balloon catheter may be deployed and left permanently implanted in the body to maintain patency.
- It is therefore desirable to develop a streamlined multifunctional treatment to carry out clot capture, angioplasty and/or prevention of restenosis using a single integrated intravascular device comprising a stentriever and semi-compliant balloon eliminating the need to perform separate medical procedures using separate devices.
- An aspect of the present invention is directed to a streamlined multifunctional treatment to carry out clot capture, angioplasty and/or prevention of restenosis using a single integrated intravascular device comprising a self-expanding stentriever and semi-compliant balloon eliminating the need to perform separate medical procedures using separate devices.
- Another aspect of the present invention relates to a single integrated intravascular device including a pusher member having a proximal end, an opposite distal end; and a self-expanding stentriever comprising an open scaffolding formed by multiple struts secured together. The self-expanding stentriever is transitionable upon withdraw of an externally applied mechanical force imposed by the microcatheter between a compressed state having a reduced diameter and a self-expanded state having an enlarged diameter. Proximal and distal ends of the self-expanding stentriever are secured to the pusher member at respective proximal and distal securement points, the self-expanding stentriever is detachable or releasable from the pusher member at the respective proximal and distal securement points. The device further including a semi-compliant balloon housed within the self-expanding stentriever and secured to the pusher member extending axially through the semi-compliant balloon; and an inflation lumen defined axially in the pusher member in fluid communication with the semi-compliant balloon.
- While another aspect of the present invention is directed to a method for using a single integrated intravascular device as described in the preceding paragraph. The method including the step of advancing a guidewire and microcatheter into a vessel across a target clot. The guidewire is then proximally withdrawn while maintaining in position the microcatheter in the vessel traversing the target clot. While the self-expanding stentriever is in the compressed state with the semi-compliant balloon in a deflated state housed therein, the single integrated intravascular device is loaded into the lumen of the microcatheter. Then, the single integrated intravascular device is advanced through the lumen of the microcatheter using the pusher member so that the self-expanding stentriever coincides with the target clot. At this point the microcatheter is proximally withdrawn from the vessel, while the single integrated intravascular device is maintained within the vessel crossing the target clot. The self-expanding stentriever when unsheathed from the microcatheter automatically transitions to the self-expanded state engaging the target clot in the open scaffolding of the self-expanding stentriever, while the semi-compliant balloon housed within the self-expanding stentriever is maintained in a deflated state so as not to interfere with engagement and subsequent embedding of the target clot in the self-expanding stentriever.
- Still another aspect of the present invention relates to a method for using a single integrated intravascular device including a stentriever and semi-compliant balloon housed within the stentriever. The single integrated intravascular device is first introduced into a vessel to traverse a target clot. Thereafter, the stentriever is deployed to a self-expanded state and the target clot is embedded therein. The single integrated intravascular device with the embedded clot therein is removed from the vessel. Through imaging, an underlying residual stenosis in the vessel is detected at an original position of the captured target clot. Whereupon, the single integrated intravascular device is reintroduced into the vessel to a location where the stentriever coincides with the detected underlying residual stenosis. Again, the stentriever is deployed so that it transitions from a compressed state to a self-expanded state. Next, the semi-compliant balloon is inflated with inflation media to enlarge the stentriever to a hyper-expanded state having a diameter larger than the self-expanded state thereby dilating the vessel at the location of the detected underlying residual stenosis while simultaneously completely detaching or releasing the stentriever from a remaining portion of the single integrated intravascular device. The semi-compliant balloon is now collapsed by purging the inflation media therefrom. Lastly, the remaining portion of the single integral intravascular device is proximally withdrawn from the vessel, while maintaining in position within the vessel at the position of the detected underlying residual stenosis the detachable or releasable portion of the stentriever in the self-expanded state.
- The foregoing and other features of the present invention will be more readily apparent from the following detailed description and drawings illustrative of the invention wherein like reference numbers refer to similar elements throughout the several views and in which:
-
FIG. 1 is a cross-sectional view of an exemplary single integrated intravascular device including a self-expanding stentriever and semi-compliant balloon in accordance with the present invention; -
FIG. 2A depicts the guidewire and microcatheter positioned across the target clot in a vessel; -
FIG. 2B depicts, following proximal withdraw of the guidewire from the vessel, advancement through the lumen of the microcatheter the present inventive single integrated intravascular device ofFIG. 1 so that the self-expanding stentriever traverses the target clot in the vessel; -
FIG. 2C depicts, following proximal withdraw of the microcatheter from the vessel, unsheathing and automatic deployment of the self-expanding stentriever to a radially self-expanded state engaging the target clot in the open spaces of the scaffolding; -
FIG. 2D depicts the self-expanding stentriever while in a radially self-expanded state with the clot embedded therein being withdrawn proximally into a larger diameter proximal catheter; -
FIG. 2E depicts the presence of an underlying residual stenosis at the original site in the vessel of the target clot, the guidewire and microcatheter being reintroduced, simultaneously or in succession, into the vessel to a position coinciding with the underlying residual stenosis; -
FIG. 2F depicts, following proximal withdraw of the guidewire from the vessel, reloading of the present inventive single integrated intravascular device ofFIG. 1 into the lumen of the microcatheter so that the self-expanding stentriever coincides with the underlying residual stenosis; -
FIG. 2G depicts, following proximal withdraw of the microcatheter from the vessel, unsheathing and automatic deployment of the self-expanding stentriever to a radially self-expanded state at the location of the detected underlying residual stenosis; -
FIG. 2H depicts, inflation of the semi-compliant balloon housed within the self-expanding stentriever, to dilate the vessel at the detected underlying residual stenosis; the self-expanding stentriever is illustrated in a hyper-expanded state larger in diameter than that when in the self-expanded state ofFIG. 2G ; -
FIG. 2I depicts, following fracture of the frangible sections of the scaffolding of the self-expanding stentriever when deformed by the inflated semi-compliant balloon and thereafter deflating of the semi-compliant balloon, proximal withdraw from the vessel as a single unit the remnant portions of the self-expanding stentriever that remain secured to the pusher shaft along with the deflated balloon, while permanently maintaining in position within the vessel the detachable portion of the self-expanding stentriever in the self-expanded state to prevent restenosis; -
FIG. 2J is an enlarged area of a section II(J) of struts of the self-expanding stentriever inFIG. 2H having a thinner cross-section to promote fracturing when the semi-compliant balloon is inflated causing the self-expanding stentriever to transition to a hyper-expanded state; -
FIG. 3A is a cross-sectional view of an alternative configuration of the present inventive single integrated intravascular device including a self-expanding stentriever and semi-compliant balloon in accordance with the present invention; wherein distal and proximal ends of the self-expanding stentriever are releasably secured to the pusher member via respective distal and proximal sleeves; -
FIG. 3B is a cross-sectional view of the single integrated intravascular device ofFIG. 3A after the self-expanding stentriever has been unsheathed from the microcatheter and transitioning to the self-expanded state; -
FIG. 3C is a cross-sectional view of the single integrated intravascular device ofFIG. 3A when the semi-compliant balloon has been inflated resulting in radial expansion of the self-expanding stentriever to a hyper-expanded state (having a greater diameter than the self-expanded state inFIG. 3B ) simultaneously with a foreshortening axially of the respective proximal and distal ends of the self-expanding stentriever; and -
FIG. 3D is a cross-sectional view of the single integrated intravascular device ofFIG. 3A with the proximal and distal ends of self-expanding stentriever released or disengaged from the respective proximal and distal sleeves allowing the released self-expanded stentriever to return to its pre-formed shape. - The terms “distal” or “proximal” are used in the following description with respect to a position or direction relative to the treating physician or medical interventionalist. “Distal” or “distally” are a position distant from or in a direction away from the physician or interventionalist. “Proximal” or “proximally” or “proximate” are a position near or in a direction toward the physician or medical interventionalist. The terms “occlusion”, “clot”, thrombus, or “blockage” are used interchangeably.
- The present invention is directed to a single integrated intravascular device that includes a self-expanding stentriever and a semi-compliant balloon. The term “semi-compliant balloon” is herein defined as a balloon that distends approximately 10% of the diameter between the nominal pressure (pressure at labeled diameter) and the rated burst pressure (95% confidence that 99.9% will not fail at or below rated burst). Exemplary semi-compliant balloon materials include, but are not limited to, Polyethylene, Polyolefin Copolymer or Polyamide (Nylon). Heretofore, multiple intravascular treatments (clot removal; angioplasty; prevention of restenosis) were performed in succession, one following the other, each employing a different separate device dedicated exclusively to only one treatment or procedure. With the present inventive single integrated intravascular device, multiple intravascular treatments or procedures may now be carried out in a single streamlined procedure saving time, reducing device exchanges and providing the interventionalist flexibility to permanently deploy a stent scaffold at any point in the thrombectomy procedure. This single integrated intravascular device may be used to carry out multiple intravascular treatments or procedures including clot capture/removal, angioplasty and/or prevention of restenosis.
- Referring to
FIG. 1 , the present inventive single integratedintravascular device 100 includes a mechanical thrombectomy device (e.g., self-expanding stentriever) 115 comprising an open mesh, cage, scaffolding, or skeleton formed by a plurality of struts connected together with spaces oropenings 116 defined therebetween through which the clot may be engaged, captured and over time embed. Self-expandingstentriever 115 is made of an automatically self-expanding material (e.g., a biocompatible superelastic shape memory material such as Nitinol (e.g., Nickel-Titanium)) that may be crimped-down or reduced in diameter to a compressed state receivable within a lumen of a microcatheter, as described in further detail below. Housed within the self-expandingstentriever 115 is a deflatedsemi-compliant balloon 120. Proximal and distal ends of each of thesemi-compliant balloon 120 and self-expandingstentriever 115 are secured (e.g., fused) at respective proximal and distal securement points 117, 117′ to a proximal shaft orpusher member 125. As is illustrated inFIG. 1 , a proximal section of thepusher member 125 extends proximally to and axially completely through thesemi-compliant balloon 120, while a distal section of thepusher member 125 extends outward beyond the distal end of thesemi-compliant balloon 120 and self-expandingstentriever 115. The stiffness ofpusher member 125 preferably varies along its axial length from a stiff proximal end relative to a more pliable distal end extending axially beyond the semi-compliant balloon and self-expanding stentriever. Defined axially through a portion of the proximal section of thepusher member 125 and in fluid communication with thesemi-compliant balloon 120 is an inflation/deflation lumen 127 for receiving an inflation media (e.g., 50% contrast saline solution) used to inflate/deflate thesemi-compliant balloon 120. As is evident from the illustration inFIG. 1 , the inflation/deflation lumen 127 is in fluid communication with the semi-compliant balloon, without extending axially beyond the semi-compliant balloon into the distal section of thepusher member 125. - Heretofore, multifunctional intravascular medical procedures (i.e., clot capture/retrieval; angioplasty; and thereafter implantation of a permanent stent to prevent restenosis) all required different separate medical devices used in successive medical treatments. These separate medical treatments have been streamlined using the present inventive single integrated intravascular device. A general overview of the multifunctional application of the present inventive single integrated intravascular device is provided, the specific details of operating the device follow in the description thereafter. Initially the target clot may be captured using the self-expanding stentriever component of the present inventive single integrated intravascular device and withdrawn into a proximal catheter. Thereafter, imaging may be conducted to determine whether underlying residual stenosis is present at the original site of the target clot. If the presence of underlying residual stenosis is detected at the original site of the target clot, the same single integrated
intravascular device 100 may be reloaded into the microcatheter and reintroduced back to the original site of the target clot where the underlying residual stenosis has been detected. At that original site in the vessel angioplasty may be performed on the underlying residual stenosis dilating the opening of the artery to restore blood flow therethrough by inflating the semi-compliant balloon housed within the self-expanding stentriever. With inflation of the semi-compliant balloon the self-expanding stentriever may be detached or released (freed) from the remaining portion of the single integrated intravascular device. The remaining portion of the single integrated intravascular device may thereafter be withdrawn leaving behind permanently in the vessel the detached or released (freed) portion of the self-expanding stentriever while in the self-expanded state to prevent elastic vessel recoil or restenosis. - A detailed description of the use of the single integrated intravascular device follows below. Because the present inventive single integrated intravascular device employs a semi-compliant balloon, prior to introduction into the body the single integrated device is prepped by removing, purging, or exhausting residual air from the device. Removal of the residual air may be achieved by applying a vacuum using a
syringe 110 or other mechanical device connected to aproximal hub 105. The exemplary illustration inFIG. 1 shows a single inflation/deflation lumen 127, however, it is contemplated and within the intended scope of the present invention for separate inflation and deflation lumen (arranged coaxially or side-by-side) to be employed, as desired. - Once prepped, use of the present inventive single
integrated device 100 begins by introducing aguidewire 200 into anartery 205 and advancing the guidewire across the target clot, thrombus, occlusion orblockage 210, as shown inFIG. 2A . Thereafter, amicrocatheter 220 having alumen 225 defined axially therein is tracked over theguidewire 200 until itsdistal end 230 crosses and emerges distally beyond thetarget clot 210.Guidewire 200 is then proximally withdrawn from the vessel while maintaining the position of themicrocatheter 220 in thevessel 205 traversing thetarget clot 210. Referring toFIG. 2B , while the self-expandingstentriever 115 is in a compressed state (e.g., sheathed by the microcatheter so as to be crimped-down having a reduced diameter) with the deflatedsemi-compliant balloon 120 housed therein, the single integratedintravascular device 100 is introduced into thelumen 225 of themicrocatheter 220. Guided by imaging, the single integratedintravascular device 100 is advanced through thelumen 225 of themicrocatheter 220 using thepusher member 125 so that the self-expandingstentriever 115 traverses thetarget clot 210. Referring toFIG. 2C , themicrocatheter 220 is then retracted or withdrawn proximally while the single integratedintravascular device 100 remains in place within thevessel 205 traversing/crossing thetarget clot 210. As themicrocatheter 220 is proximally retracted from thevessel 205 it unsheathes or frees the self-expandingstentriever 115 disposed therein which automatically transitions to a self-expand state having an enlarged diameter thereby engaging thetarget clot 210 in theopen spaces 116 of the mesh or scaffolding structure. While the scaffolding or skeleton structure of the self-expandingstentriever 115 expands radially outward, thesemi-compliant balloon 120 housed therein remains in a deflated state so as not to interfere with engagement and subsequent embedding of thetarget clot 210. Over time (e.g., approximately 2-5 minutes) thetarget clot 210 sufficiently embeds in the spacings oropenings 116 of the scaffolding of the self-expandingstentriever 115. Thereafter, thetarget clot 210 embedded in the self-expandingstentriever 115 together with the deflatedsemi-compliant balloon 120 housed therein are withdrawn proximally as a single unit and received in aproximal catheter 235 having a diameter sufficiently large in size to accommodate the self-expanding stentriever 115 (which in a self-expanded state) without compressing and stripping off the target clot, as depicted inFIG. 2D . - The functionality of the present inventive single integrated intravascular device does not necessarily end. Now that the self-expanding
stentriever 115 and capturedtarget clot 210 therein have been received in theproximal catheter 235 and withdrawn from thevessel 205, the presence of any underlyingresidual stenosis 215 at the original site of the captured target clot may be detected through imaging. - If
residual stenosis 215 is detected during imaging, the single integratedintravascular device 100 may be cleaned and reloaded into themicrocatheter 220. Similar to that inFIG. 2A (but thetarget clot 210 has already been captured and removed from the vessel), theguidewire 200 andmicrocatheter 220, either successively (one after the other) or simultaneously at the same time, are reintroduced and tracked through thevessel 205 to the detected underlyingresidual stenosis 215, as illustrated inFIG. 2E .Guidewire 200 is then proximally withdrawn from the vessel leaving themicrocatheter 220 in position coinciding with the underlyingresidual stenosis 215. While the self-expandingstentriever 115 is in the compressed state (i.e., crimped-down having a reduced diameter) with the deflatedsemi-compliant balloon 120 housed therein, the single integratedintravascular device 100 is reloaded into themicrocatheter 220 and advanced so that the self-expandingstentriever 115 coincides with the underlyingresidual stenosis 215, as shown inFIG. 2F . Referring toFIG. 2G ,microcatheter 220 is withdrawn proximally from thevessel 205 unsheathing the self-expandingstentriever 115 allowing it to automatically enlarge radially to the self-expanded state. With the self-expandingstentriever 115 in the self-expanded state, thesyringe 110 dispenses under pressure the inflation media through theinflation lumen 127 of thepusher member 125 filling thesemi-compliant balloon 120. Self-expandingstentriever 115 may be configured so that some portions of the scaffolding or struts include weakened orfrangible sections 111 disposed at multiple strut locations proximate the proximal and distal securement points to thepusher member 125. Thefrangible sections 111 of the self-expanding stentriever may be designed as sections of the struts having a thinner cross-section (as depicted inFIG. 2J ), or as struts with focal stress risers (notches). - As the
semi-compliant balloon 120 inflates imposing a radially outward force, the self-expandingstentriever 115 hyper-expands to a diameter larger than the self-expanding state while adopting the curved contour of the inflated semi-compliant balloon, as shown inFIG. 2H . The inflated balloon enlarges or dilates the narrow opening of the vessel in which there is a build-up of plaque improving blood flow therethrough. - At some point during inflation of the
semi-compliant balloon 120, sufficient radially outward force is imposed to deform thefrangible sections 111 of the self-expandingstentriever 115 causing thefrangible sections 111 to fracture or break. Fracturing of thefrangible sections 111 completely frees or releases adetachable portion 130′ of self-expandingstentriever 115 from that that ofremnant portions 130 of the self-expandingstentriever 115 that remain secured to thepusher member 125 at respective proximal and distal securement points. A negative pressure is applied using thesyringe 110 expelling the inflation media via the inflation/deflation lumen 127 of thepusher member 125 so that the collapsedsemi-compliant balloon 120 may be withdrawn from the vessel. As thesemi-compliant balloon 120 collapses, thedetachable portion 130′ of the self-expanding stentriever transitions from the hyper-expanded state (FIG. 2H ) back to the smaller diameter self-expanded state (FIG. 2I ).FIG. 2I further depicts the severeddetachable portion 130′ of the self-expanding stentriever maintained in thevessel 205 in the self-expanded state, while theremnant portions 130 secured to thepusher member 125 together with the deflatedsemi-compliant balloon 120 are proximally withdrawn from the vessel as a single unit.Detachable portion 130′ of the self-expandingstentriever 115 in the self-expanded state remains permanently in the vessel at the position in which residual stenosis was detected to prevent restenosis. Accordingly, the probability of restenosis (re-narrowing of the opening of the artery) that occurs (typically within approximately 6-12 months) following dilation of the vessel opening by the inflated balloon is prevented or reduced by the detachable portion of the self-expanding stentriever permanently remaining in place in the vessel. - Instead of designing the struts of the self-expanding stentriever to have
frangible sections 111 that break or fracture when deformed, the self-expanding stentriever may alternatively be releasably secured to the pusher member. By way of illustrative example,FIG. 3A depicts an alternative configuration, wherein the self-expanding stentriever 315 (while in a crimped state) with the deflatedsemi-compliant balloon 320 disposed therein together are advanced through themicrocatheter 370 to a target site in the vessel. Proximal and distal end struts of the self-expandingstentriever 315 are secured to thepusher member 325 via proximal and distal sleeves or endcaps microcatheter 370 is withdrawn proximally, the self-expandingstentriever 315 no longer constrained by the microcatheter automatically self-expands increasing in diameter to a self-expanded state, as shown inFIG. 3B . Despite such expansion, the distal and proximal end struts of the self-expandingstentriever 315 nevertheless remain constrained or secured by the proximal anddistal sleeves stentriever 315 while in the self-expanded state may be employed similar to that described above with respect toFIGS. 2A-2J to engage and remove the target clot. If, subsequent to removing the target clot, through imaging a stenosis is detected at the site of the removed target clot, the device may be cleaned and reloaded into the vessel to the target site, once again following the description and procedure above regarding the design ofFIGS. 2A-2J . Once the self-expanding stentriever is positioned at the target site themicrocatheter 370 is proximally withdrawn. The unsheathing of the crimped-down self-expandingstentriever 315 increases its diameter to a self-expanded state, nevertheless the distal and proximal end struts of the self-expanding stentriever remain secured to thepusher member 325 beneath the respective proximal anddistal sleeves FIG. 3C , thesemi-compliant balloon 320 is inflated causing the self-expandingstentriever 315 to transition to a hyper-expanded state (i.e., having a diameter greater than that in a self-expanded state when the self-expanding stentriever is unsheathed by the microcatheter but remains secured by the proximal anddistal sleeves FIG. 3B ). Inflation ofsemi-compliant balloon 320 to the hyper-expanded state, increases in diameter (direction traverse to the axial direction—as denoted by the larger arrows) and, in turn, causes a foreshortening of the self-expanding stentriever (axial direction—as denoted by the smaller arrows drawn towards one another) to such extent that the distal and proximal end struts of the self-expanding stentriever are freed from or disengage (no longer secured by) the proximal anddistal sleeves FIG. 3D ), the distal and proximal end struts of the self-expanding stentriever expand automatically in diameter to their pre-formed shape in direct physical contact with the inner wall of the vessel at the target site of the stenosis. Thereafter,semi-compliant balloon 320 may be deflated and removed proximally along with thesleeves pusher member 325, while the detached (freed) self-expandingstentriever 315 permanently remains in physical contact with the inner wall of thevessel 305 at the target site. - Regardless of the particular design or configuration of the device, if the self-expanding stentriever is substantially “waisted” indicating an inability to embed into the target clot while the presence of an underlying stenosis is probable, the step of removing the target clot may be bypassed entirely. In such case, the interventionalist may proceed directly to inflating the semi-compliant balloon causing the self-expanding stentriever to transition to a hyper-expanded state and detaching/releasing itself from the pusher member, without attempting to remove or withdraw the clot. After deflation, the semi-compliant balloon is withdrawn together with the pusher member, leaving in place at the site of the stenosis the detached/released self-expanding stentriever in the self-expanded state in physical contact against the wall of the vessel.
- Thus, the present inventive single integrated intravascular device is used to perform multifunctional treatment including: (i) capturing and removing the target clot; (ii) dilating the narrowed opening of a vessel in which an underlying residual stenosis is detected beneath the target clot after removal; and/or (iii) permanently maintaining the detachable/releasable (freed) self-expanding stentriever in the vessel at the location of the detected underlying residual stenosis to prevent restenosis.
- Thus, while there have been shown, described, and pointed out fundamental novel features of the invention as applied to a preferred embodiment thereof, it will be understood that various omissions, substitutions, and changes in the form and details of the systems/devices illustrated, and in their operation, may be made by those skilled in the art without departing from the spirit and scope of the invention. For example, it is expressly intended that all combinations of those elements and/or steps that perform substantially the same function, in substantially the same way, to achieve the same results be within the scope of the invention. Substitutions of elements from one described embodiment to another are also fully intended and contemplated. It is also to be understood that the drawings are not necessarily drawn to scale, but that they are merely conceptual in nature. It is the intention, therefore, to be limited only as indicated by the scope of the claims appended hereto.
- Every issued patent, pending patent application, publication, journal article, book or any other reference cited herein is each incorporated by reference in their entirety.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/585,473 US20220142662A1 (en) | 2019-07-10 | 2022-01-26 | Streamlined Treatment of Clot Removal, Angioplasty and Prevention of Restenosis Using a Single Integrated Intravascular Device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/508,121 US11266426B2 (en) | 2019-07-10 | 2019-07-10 | Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device |
US17/585,473 US20220142662A1 (en) | 2019-07-10 | 2022-01-26 | Streamlined Treatment of Clot Removal, Angioplasty and Prevention of Restenosis Using a Single Integrated Intravascular Device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/508,121 Continuation US11266426B2 (en) | 2019-07-10 | 2019-07-10 | Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220142662A1 true US20220142662A1 (en) | 2022-05-12 |
Family
ID=71575076
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/508,121 Active 2040-05-19 US11266426B2 (en) | 2019-07-10 | 2019-07-10 | Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device |
US17/585,473 Pending US20220142662A1 (en) | 2019-07-10 | 2022-01-26 | Streamlined Treatment of Clot Removal, Angioplasty and Prevention of Restenosis Using a Single Integrated Intravascular Device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/508,121 Active 2040-05-19 US11266426B2 (en) | 2019-07-10 | 2019-07-10 | Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device |
Country Status (5)
Country | Link |
---|---|
US (2) | US11266426B2 (en) |
EP (1) | EP3763307A1 (en) |
JP (1) | JP2021013743A (en) |
KR (1) | KR20210007887A (en) |
CN (1) | CN112206036A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11266426B2 (en) * | 2019-07-10 | 2022-03-08 | DePuy Synthes Products, Inc. | Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device |
KR102546468B1 (en) * | 2021-02-08 | 2023-06-22 | (주)시지바이오 | APPARATUS AND METHOD for medical member insertion |
CN113274170A (en) * | 2021-05-26 | 2021-08-20 | 上海微创心通医疗科技有限公司 | Implant delivery device |
IL310309A (en) | 2021-08-31 | 2024-03-01 | Toray Industries | Balloon catheter |
CN113925652A (en) * | 2021-09-30 | 2022-01-14 | 艾柯医疗器械(北京)有限公司 | Mechanical balloon, stent conveying device and stent system |
CN116942253B (en) * | 2023-09-20 | 2023-12-01 | 杭州亿科医疗科技有限公司 | Radial supporting force adjustable thrombus taking device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010032008A1 (en) * | 1999-06-14 | 2001-10-18 | William E. Anderson | Stent securement sleeves and optional coatings and methods of use |
US20020099405A1 (en) * | 1992-12-30 | 2002-07-25 | Yurek Matthew T. | Apparatus for deploying body implantable stents |
US20110251674A1 (en) * | 2010-04-10 | 2011-10-13 | Reva Medical, Inc. | Expandable slide and lock stent |
US11266426B2 (en) * | 2019-07-10 | 2022-03-08 | DePuy Synthes Products, Inc. | Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device |
Family Cites Families (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766192A (en) | 1995-10-20 | 1998-06-16 | Zacca; Nadim M. | Atherectomy, angioplasty and stent method and apparatus |
US6544276B1 (en) | 1996-05-20 | 2003-04-08 | Medtronic Ave. Inc. | Exchange method for emboli containment |
US6837901B2 (en) | 2001-04-27 | 2005-01-04 | Intek Technology L.L.C. | Methods for delivering, repositioning and/or retrieving self-expanding stents |
US6821291B2 (en) | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US7371228B2 (en) | 2003-09-19 | 2008-05-13 | Medtronic Vascular, Inc. | Delivery of therapeutics to treat aneurysms |
ATE491416T1 (en) | 2004-03-31 | 2011-01-15 | Cook Inc | STENT DEPOSITION DEVICE |
US9308382B2 (en) | 2004-06-10 | 2016-04-12 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US9636115B2 (en) | 2005-06-14 | 2017-05-02 | Stryker Corporation | Vaso-occlusive delivery device with kink resistant, flexible distal end |
CA2612679A1 (en) | 2005-06-20 | 2007-01-04 | Richardo D. Roman | Ablation catheter |
EP1973680B1 (en) | 2005-11-17 | 2018-01-10 | Microvention, Inc. | Three-dimensional complex coil |
US9757260B2 (en) | 2006-03-30 | 2017-09-12 | Medtronic Vascular, Inc. | Prosthesis with guide lumen |
US9615832B2 (en) | 2006-04-07 | 2017-04-11 | Penumbra, Inc. | Aneurysm occlusion system and method |
KR101443926B1 (en) | 2006-06-15 | 2014-10-02 | 마이크로벤션, 인코포레이티드 | Embolization device constructed from expansible polymer |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
WO2009086208A2 (en) | 2007-12-21 | 2009-07-09 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
US8974518B2 (en) | 2008-03-25 | 2015-03-10 | Medtronic Vascular, Inc. | Eversible branch stent-graft and deployment method |
EP2192947A1 (en) | 2008-04-30 | 2010-06-09 | Medtronic, Inc. | Techniques for placing medical leads for electrical stimulation of nerve tissue |
US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
CA2737653C (en) | 2008-09-22 | 2018-02-27 | Hotspur Technologies, Inc. | Flow restoration systems and methods for use |
JP5608731B2 (en) | 2009-04-15 | 2014-10-15 | マイクロベンション インコーポレイテッド | Implant delivery system |
US20100305678A1 (en) | 2009-05-27 | 2010-12-02 | Khaldoon Alaswad | Thrombectomy and Balloon Angioplasty/Stenting Device |
US8740961B2 (en) | 2009-08-13 | 2014-06-03 | Richard Eustis Fulton, III | Method for treating a target site in a vascular body channel |
US20150313732A1 (en) | 2009-08-13 | 2015-11-05 | Quadra Endovascular, Inc. | Method and Device for Treating a Target Site in a Vascular Body Channel |
US8911487B2 (en) | 2009-09-22 | 2014-12-16 | Penumbra, Inc. | Manual actuation system for deployment of implant |
AU2011240927B2 (en) | 2010-04-14 | 2015-07-16 | Microvention, Inc. | Implant delivery device |
US8764811B2 (en) | 2010-04-20 | 2014-07-01 | Medtronic Vascular, Inc. | Controlled tip release stent graft delivery system and method |
US8876878B2 (en) | 2010-07-23 | 2014-11-04 | Medtronic, Inc. | Attachment mechanism for stent release |
US8616040B2 (en) | 2010-09-17 | 2013-12-31 | Medtronic Vascular, Inc. | Method of forming a drug-eluting medical device |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
WO2012088162A1 (en) | 2010-12-20 | 2012-06-28 | Microvention, Inc. | Polymer stents and methods of manufacture |
US9486604B2 (en) | 2011-05-12 | 2016-11-08 | Medtronic, Inc. | Packaging and preparation tray for a delivery system |
DE102011101522A1 (en) | 2011-05-13 | 2012-11-15 | Phenox Gmbh | thrombectomy |
WO2012158668A1 (en) | 2011-05-17 | 2012-11-22 | Stryker Corporation | Method of fabricating an implantable medical device that includes one or more thin film polymer support layers |
WO2012166467A1 (en) | 2011-05-27 | 2012-12-06 | Stryker Corporation | Assembly for percutaneously inserting an implantable medical device, steering the device to a target location and deploying the device |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
EP2825129B2 (en) | 2012-03-16 | 2020-02-19 | Terumo Corporation | Stent and stent delivery device |
US9833625B2 (en) | 2012-03-26 | 2017-12-05 | Medtronic, Inc. | Implantable medical device delivery with inner and outer sheaths |
US9717421B2 (en) | 2012-03-26 | 2017-08-01 | Medtronic, Inc. | Implantable medical device delivery catheter with tether |
US9242290B2 (en) | 2012-04-03 | 2016-01-26 | Medtronic Vascular, Inc. | Method and apparatus for creating formed elements used to make wound stents |
US9549832B2 (en) | 2012-04-26 | 2017-01-24 | Medtronic Vascular, Inc. | Apparatus and methods for filling a drug eluting medical device via capillary action |
US9700399B2 (en) | 2012-04-26 | 2017-07-11 | Medtronic Vascular, Inc. | Stopper to prevent graft material slippage in a closed web stent-graft |
US9149190B2 (en) | 2012-07-17 | 2015-10-06 | Stryker Corporation | Notification system of deviation from predefined conditions |
WO2014028528A1 (en) | 2012-08-13 | 2014-02-20 | Microvention, Inc. | Shaped removal device |
US9504476B2 (en) | 2012-10-01 | 2016-11-29 | Microvention, Inc. | Catheter markers |
KR102275634B1 (en) | 2012-10-15 | 2021-07-08 | 마이크로벤션, 인코포레이티드 | Polymeric treatment compositions |
US9539022B2 (en) | 2012-11-28 | 2017-01-10 | Microvention, Inc. | Matter conveyance system |
ES2759989T3 (en) | 2012-12-05 | 2020-05-12 | Rapid Medical Ltd | Devices to assist medical treatments |
CN104797291B (en) | 2012-12-07 | 2017-09-12 | 美敦力公司 | Minimally invasive implantable neural stimulation system |
US9539382B2 (en) | 2013-03-12 | 2017-01-10 | Medtronic, Inc. | Stepped catheters with flow restrictors and infusion systems using the same |
EP2967575B1 (en) | 2013-03-14 | 2019-07-31 | Stryker Corporation | Vaso-occlusive device delivery system |
US9451964B2 (en) | 2013-03-14 | 2016-09-27 | Stryker Corporation | Vaso-occlusive device delivery system |
EP2967573B1 (en) | 2013-03-14 | 2021-04-21 | Stryker Corporation | Vaso-occlusive device delivery system |
US9693852B2 (en) | 2013-03-15 | 2017-07-04 | Microvention, Inc. | Embolic protection device |
US9398966B2 (en) | 2013-03-15 | 2016-07-26 | Medtronic Vascular, Inc. | Welded stent and stent delivery system |
US9833252B2 (en) | 2013-03-15 | 2017-12-05 | Microvention, Inc. | Multi-component obstruction removal system and method |
ES2717678T3 (en) | 2013-04-22 | 2019-06-24 | Stryker European Holdings I Llc | Procedure for loading drugs onto implant surfaces coated with hydroxyapatite |
US9445928B2 (en) | 2013-05-30 | 2016-09-20 | Medtronic Vascular, Inc. | Delivery system having a single handed deployment handle for a retractable outer sheath |
US9675782B2 (en) | 2013-10-10 | 2017-06-13 | Medtronic Vascular, Inc. | Catheter pull wire actuation mechanism |
US9955978B2 (en) | 2013-10-25 | 2018-05-01 | Medtronic Vascular, Inc. | Tissue compression device with multi-chamber bladder |
EP3082939B1 (en) | 2013-12-20 | 2020-12-02 | MicroVention, Inc. | Delivery adapter |
JP6492087B2 (en) | 2013-12-20 | 2019-03-27 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Device delivery system |
CN106163459B (en) | 2014-04-08 | 2018-05-29 | 斯瑞克公司 | Implantation material delivery system |
US20170049596A1 (en) | 2014-04-30 | 2017-02-23 | Stryker Corporation | Implant delivery system and method of use |
US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
US9668898B2 (en) | 2014-07-24 | 2017-06-06 | Medtronic Vascular, Inc. | Stent delivery system having dynamic deployment and methods of manufacturing same |
US9770577B2 (en) | 2014-09-15 | 2017-09-26 | Medtronic Xomed, Inc. | Pressure relief for a catheter balloon device |
US9579484B2 (en) | 2014-09-19 | 2017-02-28 | Medtronic Vascular, Inc. | Sterile molded dispenser |
US9692557B2 (en) | 2015-02-04 | 2017-06-27 | Stryker European Holdings I, Llc | Apparatus and methods for administering treatment within a bodily duct of a patient |
CA3029186C (en) | 2015-07-24 | 2022-03-15 | Ichor Vascular Inc. | Embolectomy system and methods of making and using same |
US10154905B2 (en) | 2015-08-07 | 2018-12-18 | Medtronic Vascular, Inc. | System and method for deflecting a delivery catheter |
US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
EP3334354B1 (en) | 2015-08-11 | 2021-03-03 | Terumo Corporation | System for implant delivery |
JP6816126B2 (en) | 2015-09-18 | 2021-01-20 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Releasable delivery system |
CN113244032B (en) | 2015-09-18 | 2023-06-27 | 泰尔茂株式会社 | Pushable implant delivery system |
CN113952095A (en) | 2015-09-18 | 2022-01-21 | 微仙美国有限公司 | Implant retention, detachment and delivery system |
EP3349669B1 (en) | 2015-09-18 | 2020-10-21 | Terumo Corporation | Vessel prosthesis |
EP3352688B1 (en) | 2015-09-21 | 2020-02-19 | Stryker Corporation | Embolectomy devices |
ES2716926T3 (en) | 2015-09-21 | 2019-06-18 | Stryker Corp | Embolectomy devices |
US10172632B2 (en) | 2015-09-22 | 2019-01-08 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a stabilization tube |
US10327791B2 (en) | 2015-10-07 | 2019-06-25 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon |
US20170100143A1 (en) | 2015-10-07 | 2017-04-13 | Stryker Corporation | Multiple barrel clot removal devices |
US10786302B2 (en) | 2015-10-09 | 2020-09-29 | Medtronic, Inc. | Method for closure and ablation of atrial appendage |
US10271873B2 (en) | 2015-10-26 | 2019-04-30 | Medtronic Vascular, Inc. | Sheathless guide catheter assembly |
WO2017087816A1 (en) | 2015-11-19 | 2017-05-26 | Penumbra, Inc. | Systems and methods for treatment of stroke |
US10631946B2 (en) | 2015-11-30 | 2020-04-28 | Penumbra, Inc. | System for endoscopic intracranial procedures |
US10369326B2 (en) | 2015-12-09 | 2019-08-06 | Medtronic Vascular, Inc. | Catheter with a lumen shaped as an identification symbol |
US10159568B2 (en) | 2015-12-14 | 2018-12-25 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
US10500046B2 (en) | 2015-12-14 | 2019-12-10 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
CN114732470A (en) | 2015-12-30 | 2022-07-12 | 斯瑞克公司 | Embolization device and method of making same |
US20170189033A1 (en) | 2016-01-06 | 2017-07-06 | Microvention, Inc. | Occlusive Embolic Coil |
US10070950B2 (en) | 2016-02-09 | 2018-09-11 | Medtronic Vascular, Inc. | Endoluminal prosthetic assemblies, and associated systems and methods for percutaneous repair of a vascular tissue defect |
AU2017217879B9 (en) | 2016-02-10 | 2021-08-19 | Microvention, Inc. | Intravascular treatment site access |
CA3014316A1 (en) | 2016-02-10 | 2017-08-17 | Microvention, Inc. | Devices for vascular occlusion |
US10265089B2 (en) | 2016-02-12 | 2019-04-23 | Covidien Lp | Vascular device visibility |
US10188500B2 (en) | 2016-02-12 | 2019-01-29 | Medtronic Vascular, Inc. | Stent graft with external scaffolding and method |
EP3416568A4 (en) | 2016-02-16 | 2019-10-16 | Insera Therapeutics, Inc. | Aspiration devices and anchored flow diverting devices |
EP3436124B1 (en) | 2016-03-31 | 2022-08-31 | Medtronic Vascular Inc. | Expandable introducer sheath having a steering mechanism |
US20170281331A1 (en) | 2016-03-31 | 2017-10-05 | Medtronic Vascular, Inc. | Endoluminal prosthetic devices having fluid-absorbable compositions for repair of a vascular tissue defect |
US10695542B2 (en) | 2016-04-04 | 2020-06-30 | Medtronic Vascular, Inc. | Drug coated balloon |
US10252024B2 (en) | 2016-04-05 | 2019-04-09 | Stryker Corporation | Medical devices and methods of manufacturing same |
US10441407B2 (en) | 2016-04-12 | 2019-10-15 | Medtronic Vascular, Inc. | Gutter filling stent-graft and method |
US9987122B2 (en) | 2016-04-13 | 2018-06-05 | Medtronic Vascular, Inc. | Iliac branch device and method |
US10010403B2 (en) | 2016-04-18 | 2018-07-03 | Medtronic Vascular, Inc. | Stent-graft prosthesis and method of manufacture |
US20170304097A1 (en) | 2016-04-21 | 2017-10-26 | Medtronic Vascular, Inc. | Stent-graft delivery system having an inner shaft component with a loading pad or covering on a distal segment thereof for stent retention |
US10940294B2 (en) | 2016-04-25 | 2021-03-09 | Medtronic Vascular, Inc. | Balloon catheter including a drug delivery sheath |
ES2792100T3 (en) | 2016-04-25 | 2020-11-10 | Stryker Corp | Clot retention mechanical thrombectomy appliances |
EP3590446B1 (en) | 2016-04-25 | 2021-01-06 | Stryker Corporation | Anti-jamming and macerating thrombectomy apparatuses |
US10517711B2 (en) | 2016-04-25 | 2019-12-31 | Medtronic Vascular, Inc. | Dissection prosthesis system and method |
WO2017189591A1 (en) | 2016-04-25 | 2017-11-02 | Stryker Corporation | Inverting mechanical thrombectomy apparatuses and methods of use in the vasculature |
US10191615B2 (en) | 2016-04-28 | 2019-01-29 | Medtronic Navigation, Inc. | Method and apparatus for image-based navigation |
US11147952B2 (en) | 2016-04-28 | 2021-10-19 | Medtronic Vascular, Inc. | Drug coated inflatable balloon having a thermal dependent release layer |
US10406011B2 (en) | 2016-04-28 | 2019-09-10 | Medtronic Vascular, Inc. | Implantable medical device delivery system |
US10292844B2 (en) | 2016-05-17 | 2019-05-21 | Medtronic Vascular, Inc. | Method for compressing a stented prosthesis |
CN109890452B (en) | 2016-06-01 | 2021-08-17 | 微仙美国有限公司 | Balloon catheter with improved reinforcement |
EP3463114B1 (en) | 2016-06-03 | 2022-06-22 | Stryker Corporation | Inverting thrombectomy apparatuses |
-
2019
- 2019-07-10 US US16/508,121 patent/US11266426B2/en active Active
-
2020
- 2020-07-09 JP JP2020118295A patent/JP2021013743A/en active Pending
- 2020-07-09 EP EP20185069.0A patent/EP3763307A1/en active Pending
- 2020-07-09 KR KR1020200084564A patent/KR20210007887A/en unknown
- 2020-07-10 CN CN202010662272.3A patent/CN112206036A/en active Pending
-
2022
- 2022-01-26 US US17/585,473 patent/US20220142662A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020099405A1 (en) * | 1992-12-30 | 2002-07-25 | Yurek Matthew T. | Apparatus for deploying body implantable stents |
US20010032008A1 (en) * | 1999-06-14 | 2001-10-18 | William E. Anderson | Stent securement sleeves and optional coatings and methods of use |
US20110251674A1 (en) * | 2010-04-10 | 2011-10-13 | Reva Medical, Inc. | Expandable slide and lock stent |
US11266426B2 (en) * | 2019-07-10 | 2022-03-08 | DePuy Synthes Products, Inc. | Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device |
Also Published As
Publication number | Publication date |
---|---|
EP3763307A1 (en) | 2021-01-13 |
KR20210007887A (en) | 2021-01-20 |
CN112206036A (en) | 2021-01-12 |
US11266426B2 (en) | 2022-03-08 |
JP2021013743A (en) | 2021-02-12 |
US20210007761A1 (en) | 2021-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220142662A1 (en) | Streamlined Treatment of Clot Removal, Angioplasty and Prevention of Restenosis Using a Single Integrated Intravascular Device | |
US11806033B2 (en) | Devices and methods for treating vascular occlusion | |
US10610390B2 (en) | Implant delivery system and method of use | |
US7776080B2 (en) | Stent delivery catheter system and method of implanting a self-expanding stent with embolic protection | |
KR102476823B1 (en) | Self-expanding device delivery apparatus with dual function bump | |
US6290710B1 (en) | Embolic protection device | |
US7147655B2 (en) | Balloon catheter for multiple adjustable stent deployment | |
US8303617B2 (en) | Embolic protection system | |
US20100211094A1 (en) | Umbrella distal embolic protection device | |
US20100191272A1 (en) | Distal access embolic protection system and methods of using the same | |
US20050021125A1 (en) | Stent delivery catheter and method of use | |
US20060129183A1 (en) | Sheathless embolic protection system | |
US20040215229A1 (en) | Stent delivery system and method | |
US20020161390A1 (en) | Balloon actuated apparatus having multiple embolic filters, and method of use | |
US20050049668A1 (en) | Self-expanding stent and stent delivery system for treatment of vascular stenosis | |
US20140214067A1 (en) | Percutaneous transluminal angioplasty device with integral embolic filter | |
JP2004267750A (en) | Expandable stent and delivery system and method | |
JP2004536665A (en) | Temporary device to capture embolic material | |
CN112741669A (en) | Thrombectomy and stent implantation system | |
EP4032490A1 (en) | Anchoring and non-occluding intravascular device for use during clot removal via aspiration and/or mechanical extraction device | |
US7927350B2 (en) | Plaque liberating device | |
Qureshi et al. | Implantation of Palmaz stents in branch pulmonary arteries using Olbert balloons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DE PUY SYNTHES PRODUCTS, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JOHNSON, KIRK;REEL/FRAME:058783/0817 Effective date: 20200130 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME SHOULD READ DEPUY SYNTHES PRODUCTS, INC. INSTEAD OF DE PUY SYNTHES PRODUCTS, INC. PREVIOUSLY RECORDED AT REEL: 058783 FRAME: 0817. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:JOHNSON, KIRK;REEL/FRAME:065744/0064 Effective date: 20200130 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |